Telemedicine and Treating Opioid Use Disorder in Rural Populations (On-Demand)-Presentation

Video Transcription

Video Summary

In this presentation, the speaker discussed their experience in emergency departments and addiction medicine in rural Northern California. They emphasized the importance of telemedicine in treating opioid use disorder and shared insights on maximizing its benefits, such as convenience, improved access to care, and the need to tailor treatment to individual patients' lives. They highlighted challenges in rural medicine, such as transportation barriers for patients accessing care, and the importance of informed consent and etiquette in telemedicine visits. The speaker also addressed the use of urine drug screens, treating patients with chronic pain using buprenorphine, and the risks of buprenorphine abuse compared to Suboxone. Lastly, they discussed treatment failures, the potential for abuse of buprenorphine, and the importance of a harm reduction approach in treating patients with opioid use disorder and co-occurring issues like benzodiazepine use.

Keywords

Substance Use Screening

Primary Care

Dr. Jennifer McNeely

American Psychiatric Association

SAMHSA-funded Providers Clinical Support System

Screening Tools

Implementation Guidance

TAPS Tool

US Preventive Services Task Force

emergency departments

addiction medicine

rural Northern California

telemedicine

opioid use disorder

individualized treatment

transportation barriers

informed consent

urine drug screens

buprenorphine abuse